Ofer Levy

This inventor holds 30 USPTO granted patents and 8 published patent applications and 6 EPO patents, primarily in Biotechnology and Computing. Top assignees: Intel Corporation, Compugen Ltd. Corporation, Bayer Aktiengesellschaft. Active years: 2011-2023.

USPTO Granted Patents = 30 (Patent Applications = 8)

% Patents Active = 43.3

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 62(Granted Patents)

Location History:

Jerusalem, IL (2011 - 2013)
D. N. Shimshon, IL (2013)
D.N Shimshon, IL (2013)
D.N Shimshon Moshav Mesilat Zion, IL (2013)
Moshav Mesilat Zion, IL (2016)
Moshav Mesisraelat Zion, IL (2015 - 2018)
Atlit, IL (2014 - 2020)
Moshav Mesilat Zion Doar Na Shimson, IL (2020 - 2023)
Doar Na Shimson, IL (2023)

Company Filing History:

Compugen Ltd. Corporation

patents

1 out of 12,266

Bayer Aktiengesellschaft

patents

4. 1 out of 386

Bayer Pharma Aktiengesellschaft

where one patent can have more than one assignee

Years Active: 2011-2023

Loading Chart...

Areas of Expertise:

PVRIG Polypeptides

ILDR2 Antagonists

Instruction Tracing

Performance Counters

Real Time Processing

Drug Targets

Dynamic Frequencies

Return Oriented Programming

Execution Profiling

Timing Packet Generation

Angiopoietin Derived Peptides

Clusterin Derived Peptide

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11795209 - PVRIG polypeptides and methods of treatment (2023-10-24),

2. 11655297 - ILDR2 antagonists and combinations thereof (2023-05-23),

3. 10795684 - Method and logic for maintaining performance counters with dynamic frequencies (2020-10-06),

4. 10592244 - Branch type logging in last branch registers (2020-03-17),

5. 10550173 - PVRIG polypeptides and methods of treatment (2020-02-04),

6. 10467011 - Thread pause processors, methods, systems, and instructions (2019-11-05),

7. 10437990 - Detection of return oriented programming attacks in a processor (2019-10-08),

8. 10331452 - Tracking mode of a processing device in instruction tracing systems (2019-06-25),

9. 10152451 - Scatter using index array and finite state machine (2018-12-11),

10. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics (2018-10-16),

11. 9971603 - Causing an interrupt based on event count (2018-05-15),

12. 9858411 - Execution profiling mechanism (2018-01-02),

13. 9716646 - Using thresholds to gate timing packet generation in a tracing system (2017-07-25),

14. 9696997 - Real time instruction trace processors, methods, and systems (2017-07-04),

15. 9690588 - Elapsed cycle timer in last branch records (2017-06-27),

Title: Exploring the Inventive Journey of Ofer Levy

Introduction: Ofer Levy, a prolific inventor hailing from Atlit, IL, has left a significant mark in the world of patents with an impressive tally of 30 innovations to his name.

Latest Patents: Among his recent groundbreaking inventions are the PVRIG polypeptides and methods of treatment, which focus on the therapeutic uses of PVRIG polypeptides. Additionally, Levy's ILDR2 antagonists and combinations thereof patent showcases novel pharmaceutical combinations with specific ILDR2 antagonists.

Career Highlights: Ofer Levy has showcased his inventive prowess in renowned companies such as Intel Corporation and Compugen Ltd., highlighting his versatile expertise in different sectors.

Collaborations: Throughout his career, Levy has collaborated with esteemed individuals in the field, including Amir Toporik and Zurit Levine, showing a commitment to partnership and innovation.

Conclusion: Ofer Levy's impactful journey as an inventor underscores his dedication to pushing boundaries and creating solutions that have the potential to positively impact various industries. With a rich portfolio of patents and a collaborative spirit, Levy continues to be a trailblazer in the world of innovation.